- Nachrichtendetail
-
07.05.2024 17:09:51 - dpa-AFX: *FDA ADVISORY COMMITTEE TO REVIEW ELI LILLY'S DONANEMAB FOR EARLY ALZHEIMER'S TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Eli Lilly & Co | 858560 | NYSE | 808,450 | 23.05.24 22:00:07 | +5,540 | +0,69% | 803,000 | 809,900 | 810,000 | 802,910 |
